Skip to main content

Table 4 The results of primary and secondary patency rates for different lesions in non-diabetes group

From: Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial

  

6 months

12 months

24 months

36 months

iliac lesions (n = 32)

primary patency rate

96.9% ± 3.1%

86.5% ± 6.3%

77.5% ± 8.3%

71.1% ± 9.8%

 

secondary patency rate

100% ± 0%

100% ± 0%

90.3% ± 6.5%

83% ± 5.7%

femoral lesions

primary patency rate

93.4% ± 3.2%

80.9% ± 5.2%

73.9% ± 6.1%

52.8% ± 8.6%

(n = 61)

secondary patency rate

95.1% ± 2.8%

93.3% ± 3.2%

88.7% ± 4.4%

83% ± 5.7%

popliteal

primary patency rate

82.6% ± 7.9%

63.2% ± 10.4%

47.7% ± 11.1%

39.8% ± 11.7%

lesions

(n = 23)

secondary patency rate

100% ± 0%

90.5% ± 6.4%

75.9% ± 9.4%

56.9% ± 11.8%

tibial

primary patency rate

73.7% ± 10.1%

55.3% ± 11.9%

34.5% ± 12%

34.5% ± 12%

lesions

(n = 19)

secondary patency rate

89.5% ± 7%

71.6% ± 10.8%

57.8% ± 12.4%

38.6% ± 13.9%